Perspectives on ROCK2 as a Therapeutic Target for Alzheimer’s Disease is a research paper published in Frontiers in Cellular Neuroscience (2021). On theSindex it has a DataRank of 0. It has been cited 44 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: AG061800, AG054719, AG063755
NIA NIH HHS
Grant: R01 AG061800
NINDS NIH HHS
Grant: T32 NS095775
NIA NIH HHS
Grant: R01 AG054719
NIA NIH HHS
Grant: RF1 AG063755
NIA NIH HHS
Grant: R01 AG057911
National Institutes of Health
Grant: 5R01AG054719-03
Targeting Rho Kinases for Alzheimer's disease Therapeutics
National Institutes of Health
Grant: 5R01AG061800-04
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
Fields of Study
Keywords
Sustainable Development Goals